Professor Michael Gordon Scott and Professor Charlotte Anne Skitterall have been recognised in the New Year Honours list 2023 for their 'service to pharmacy'.
Professor Scott Director, Medicines Optimisation Innovation Centre was one among the 1,107 people to received MBE for his 'service to pharmacy' in Northern Ireland.
In 1994 he established the first academic practice unit in the province in conjunction with the Queens University of Belfast. In 2004 he was made a fellow of the
Pharmaceutical Society of Northern Ireland. In June 2009 he was made an honorary Professor of Pharmacy Practice at QUB.
Professor Skitterall, Group Chief Pharmacist, Manchester University NHS Foundation Trust received MBE for 'services to Pharmacy'. Last year, she was appointed as a
Fellow of the Royal Pharmaceutical Society. "I think it was awarded in recognition of the work I have done as chair of the National Medicines Optimisation Clinical
Reference Group. I also supported the National Pharmacy Task and Finish Group for Covid Vaccine deployment," she commented.
This year, dozens of NHS staff have been recognised in the New Year Honours list ahead of the health service's 75th birthday.
Good news for patients whose epilepsy cannot be controlled by standard anti-seizure drugs! Next month, NHS England will introduce a cutting-edge laser beam
therapy that can prevent seizures in these individuals.
Known as Laser Interstitial Thermal Therapy (LITT), the advanced treatment targets the part of the brain causing seizures without the need for invasive surgery,
the health service said.
The new fibre optic laser therapy is being offered at King's College Hospital in London and The Walton Centre in Liverpool. Starting from June, it will be gradually
extended to eligible patients across England.
Each year, it is expected to benefit up to 50 epilepsy patients in England who are resistant to standard anti-seizure medications.
"This groundbreaking new treatment will change the lives of those with severe epilepsy improving quality of life and providing much-needed assurance," said Andrew
Stephenson, Minister of State for Health.
A Company Chemists' Association (CCA) analysis has shown that 'Pharmacy First' service in England could free up 30m+ GP appointments each year.
It has urged the Government and NHS to be even 'bolder in their ambition and go further and faster'.
The recent 'Delivery plan for recovering access to primary care' announced a 'Pharmacy First' service for England, mirroring similar approaches in Scotland and
Wales.
The association has estimated that with the added capability to supply non-prescription medicines and prescribe additional prescription-only medicines, an ambitious
'Pharmacy First' service could free up 30m+ GP appointments annually.
Harnessing community pharmacies to deliver care for minor health conditions will effectively create 11,000 urgent care centres in England.
Pharmacy professionals to be included as key stakeholders in the implementation, delivery and evaluation of a wide range of genomic services, said the Royal
Pharmaceutical Society (RPS).
RPS's statement has been developed in collaboration with pharmacy organisations who have co-badged the report, such as the British Oncology Pharmacy Association,
the UK Clinical Pharmacy Association, Association of Pharmacy Technicians and the College of Mental Health Pharmacy.
It looks at current and future roles for pharmacy professionals in genomic medicine across many aspects of practice such as person-centred care and collaboration,
professional practice, education, leadership, management and research.
Pharmacists and pharmacy technicians in the UK have already established roles in the application of genomic medicine in some areas of practice, such as antimicrobial
stewardship and infectious diseases, and the management of certain genetic conditions, such as cystic fibrosis.
The society believes, the current role of pharmacy professionals in genomics can be expanded upon in the future to both lead and support many relevant aspects of
genomic implementation. These are described across all healthcare sectors, within the Genome UK strategy produced by the UK Government, and within the implementation
plans published in England, Scotland and Wales.
Lead for Pharmacogenomics at RPS Sophie Harding said: "Pharmacy professionals are the gatekeepers of medication safety and efficacy across all areas of healthcare.
They are skilled at interpreting complex scientific data and use evidence-based medicine to maximise the benefits of treatments for patients, whilst supporting
shared decision-making with patients and the multidisciplinary team.
Boots has shut down three more stores, as it moves forward with its plan to close 300 stores across the UK over the next 12 months.
On Saturday (18 November), Boots closed its branches in Mudge Way, Plymouth; Mount Pleasant Road, Exeter; and Low Moor Road, Kirkby, Ashfield.
The NHS issued a memo to shoppers and patients who use the Plymouth branch, which is located next to Plympton Health Centre, to inform them that "you will
need to find and nominate another pharmacy to dispense your prescriptions going forward."
Patients can set their nomination by contacting their new pharmacy and requesting "they do this for you."
According to DevonLive, a note was attached to the Mount Pleasant pharmacy door that read: "Boots Mount Pleasant Store will close on Saturday, November 18 2023.
Recent uptake of COVID-19 vaccine booster doses in Europe has been "rather disappointing," an official said on Thursday (November 24), amid concerns that
protection against severe cases of the disease could weaken during the winter.
The European average rate of re-vaccination, or receiving booster doses, was only 29 per cent in the groups of people considered to be at highest risk, such as
the elderly and immunocompromised.
"It is of concern that those most at risk of hospitalisation or severe COVID are not adequately protected," the European Medicines Agency's head of health threats
and vaccines strategy, Marco Cavaleri, told a news briefing.
Though there have not been major increases in COVID-19 case rates in recent weeks, Cavaleri said that could change during the colder winter months.
Drug addiction poses a serious challenge since it impacts one's physical and mental health. However, the good news is that individuals who complete a drug
rehabilitation program can overcome this problem. If you are interested in providing rehab services, there are a couple of things you should know. Read on to
learn how to operate a rehabilitation clinic flawlessly.
KNOW THE NEEDS OF YOUR CLIENTS
The main purpose of drug rehab is to help different people overcome addictions. It is designed to heal the body and mind from the negative effects of addiction.
It also teaches the affected individuals to learn to live without using substances. Therefore, your first step is to conduct a comprehensive assessment of each
client to formulate a personalized treatment plan. Everyone has unique needs in their recovery journey.
Your rehab program can start with detox which is designed to rid the body of substances, although it does not treat addiction. The person affected undergoes
different therapies during treatment. Therapy helps them deal with the issues that cause substance abuse and teach them healthier ways of life. Various therapies
will be applied throughout the entire treatment process. Therefore, you must choose a suitable therapy for each individual. For instance, motivational interviewing
and cognitive behavioral therapy are the most common.